Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced a strategic alliance with Forte Research Systems, a leading provider of enterprise research software, to enhance joint offerings to research institutions.
Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced a strategic alliance with Forte Research Systems, a leading provider of enterprise research software, to enhance joint offerings to research institutions. The Huron-Forte alliance is the result of a shared commitment to offer impactful consulting services and effective software solutions to the research industry to provide clients the following:
“The Huron-Forte alliance allows both organizations to provide greater value to our shared clients,” said Rick Rohrbach, managing director, Huron Consulting Group. “Huron can help clients transform their clinical research business processes using Forte’s OnCore. Huron will help Forte customers optimize the implementation of OnCore and other Forte software solutions to improve their return on investment. Most importantly, the interfaces between our systems will provide customers a seamless and effective research administration solution.”
“The Huron-Forte relationship will help clients gain greater efficiency with their clinical trials portfolio. With increasing enterprise-wide implementations and adoption of OnCore, Huron brings the required experience in operational and implementation planning to serve a growing need,” said Srini Kalluri, president and chief executive officer, Forte Research Systems. “Existing and new OnCore clients will also be able to take advantage of a planned standards-based interface between Huron’s Click IRB and OnCore application, which will further enhance researcher productivity. Through this alliance, we are building on past success in working closely together to broadly address customer needs. The people and approaches on both sides are aligned well for taking this important step together.”
The Huron-Forte alliance aims to increase researcher productivity and improve compliance oversight through tight integration of the two companies’ products and services. Huron will expand its ability to provide clinical trials solutions beyond its current highly configurable Click Portal. At the same time, Forte gains a deployment partner with significant industry expertise and scale to accelerate the market adoption of their leading OnCore product, which includes CTMS, electronic data capture, and biospecimen management functionality.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.